US 12,002,560 B2
System and method for testing blood vessel access using powered fluid injector systems
Corey Kemper, Pittsburgh, PA (US); John Volkar, Valencia, PA (US); Michael Brooks, Croydon Park (AU); and Leona Mulcahy, Epping (AU)
Assigned to BAYER HEALTHCARE LLC, Whippany, NJ (US)
Appl. No. 17/043,883
Filed by BAYER HEALTHCARE LLC, Whippany, NJ (US)
PCT Filed Apr. 8, 2019, PCT No. PCT/US2019/026256
§ 371(c)(1), (2) Date Sep. 30, 2020,
PCT Pub. No. WO2019/199632, PCT Pub. Date Oct. 17, 2019.
Claims priority of provisional application 62/655,365, filed on Apr. 10, 2018.
Prior Publication US 2021/0125697 A1, Apr. 29, 2021
Int. Cl. A61M 5/168 (2006.01); G16H 20/17 (2018.01); G16H 40/63 (2018.01)
CPC G16H 20/17 (2018.01) [A61M 5/16827 (2013.01); G16H 40/63 (2018.01); A61M 2205/3334 (2013.01)] 25 Claims
OG exemplary drawing
 
1. A fluid injector system comprising:
a controller operably associated with at least one drive member by which at least one fluid contained within at least one fluid container is injectable into a patient,
the controller including a programming system for enabling programming of at least one diagnostic injection procedure comprising at least one diagnostic injection phase according to which the at least one fluid is to be injected into the patient so as to effect enhancement of at least one region of interest thereof over a scan duration of a diagnostic imaging procedure; and
the programming system for further enabling programming of a test injection procedure to be performed prior to the diagnostic injection procedure, wherein the test injection procedure is implementable as:
a variable single phase test injection in which a flow rate at which the at least one fluid is to be delivered is selectable prior to performance of the variable single phase test injection and may be varied during performance of the variable single phase test injection.